# China NMPA Drug Inspection - Zhuhai Federal Pharmaceutical Co., Ltd. - Amoxicillin sodium clavulanate potassium

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/zhuhai-federal-pharmaceutical-co-ltd/ecede966-9408-41cd-b61b-7675e421698f/
Source feed: China

> China NMPA drug inspection for Zhuhai Federal Pharmaceutical Co., Ltd. published July 28, 2022. Drug: Amoxicillin sodium clavulanate potassium. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Information Bulletin on Drug Quality Sampling Inspection in Qinghai Province (Issue 1, 2022)
- Company Name: Zhuhai Federal Pharmaceutical Co., Ltd.
- Publication Date: 2022-07-28
- Drug Name: Amoxicillin sodium clavulanate potassium
- Inspection Finding: qualified

Company: https://www.globalkeysolutions.net/companies/zhuhai-federal-pharmaceutical-co-ltd/bb4825c4-f115-47da-9153-e81b46bcc131/